Folate and unipolar depression

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: Although major depressive disorder (MDD) is a treatable disease, the remission rates associated with antidepressant monotherapy are still far from optimal. Folate is an inexpensive, easily tolerated natural augmenting agent, which has been reported to improve medication treatment outcomes in patients with MDD. Objective: The aim of this study was to review the literature on the clinical utility of folate augmentation for patients with MDD. Folate and depression: Patients with depression have consistently been found to have lower levels of serum and red blood cell folate than normal or nondepressed psychiatric patients. Decreased folate levels have been associated with lowered response rates to standard antidepressant pharmacotherapy. Recent studies have shown that augmentation with a folate supplement increases medication response in both treatment-naïve and treatment-resistant depressed patients irrespective of whether there is folate deficiency. Conclusions: Depressed patients with both low and normal folate levels may benefit from augmenting a primary antidepressant medication either initially, at the onset of treatment, or later after some degree of treatment resistance has been recognized.

Original languageEnglish (US)
Pages (from-to)277-285
Number of pages9
JournalJournal of Alternative and Complementary Medicine
Volume14
Issue number3
DOIs
StatePublished - Apr 1 2008

Fingerprint

Depressive Disorder
Folic Acid
Major Depressive Disorder
Antidepressive Agents
Depression
Therapeutics
Psychiatry
Erythrocytes
Drug Therapy
Serum

ASJC Scopus subject areas

  • Medicine(all)
  • Complementary and alternative medicine
  • Nursing(all)

Cite this

Folate and unipolar depression. / Morris, David W.; Trivedi, Madhukar H.; Rush, A. John.

In: Journal of Alternative and Complementary Medicine, Vol. 14, No. 3, 01.04.2008, p. 277-285.

Research output: Contribution to journalArticle

@article{5c641b529d9643bbbc9ecfbb7347975d,
title = "Folate and unipolar depression",
abstract = "Background: Although major depressive disorder (MDD) is a treatable disease, the remission rates associated with antidepressant monotherapy are still far from optimal. Folate is an inexpensive, easily tolerated natural augmenting agent, which has been reported to improve medication treatment outcomes in patients with MDD. Objective: The aim of this study was to review the literature on the clinical utility of folate augmentation for patients with MDD. Folate and depression: Patients with depression have consistently been found to have lower levels of serum and red blood cell folate than normal or nondepressed psychiatric patients. Decreased folate levels have been associated with lowered response rates to standard antidepressant pharmacotherapy. Recent studies have shown that augmentation with a folate supplement increases medication response in both treatment-na{\"i}ve and treatment-resistant depressed patients irrespective of whether there is folate deficiency. Conclusions: Depressed patients with both low and normal folate levels may benefit from augmenting a primary antidepressant medication either initially, at the onset of treatment, or later after some degree of treatment resistance has been recognized.",
author = "Morris, {David W.} and Trivedi, {Madhukar H.} and Rush, {A. John}",
year = "2008",
month = "4",
day = "1",
doi = "10.1089/acm.2007.0663",
language = "English (US)",
volume = "14",
pages = "277--285",
journal = "Journal of Alternative and Complementary Medicine",
issn = "1075-5535",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Folate and unipolar depression

AU - Morris, David W.

AU - Trivedi, Madhukar H.

AU - Rush, A. John

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Background: Although major depressive disorder (MDD) is a treatable disease, the remission rates associated with antidepressant monotherapy are still far from optimal. Folate is an inexpensive, easily tolerated natural augmenting agent, which has been reported to improve medication treatment outcomes in patients with MDD. Objective: The aim of this study was to review the literature on the clinical utility of folate augmentation for patients with MDD. Folate and depression: Patients with depression have consistently been found to have lower levels of serum and red blood cell folate than normal or nondepressed psychiatric patients. Decreased folate levels have been associated with lowered response rates to standard antidepressant pharmacotherapy. Recent studies have shown that augmentation with a folate supplement increases medication response in both treatment-naïve and treatment-resistant depressed patients irrespective of whether there is folate deficiency. Conclusions: Depressed patients with both low and normal folate levels may benefit from augmenting a primary antidepressant medication either initially, at the onset of treatment, or later after some degree of treatment resistance has been recognized.

AB - Background: Although major depressive disorder (MDD) is a treatable disease, the remission rates associated with antidepressant monotherapy are still far from optimal. Folate is an inexpensive, easily tolerated natural augmenting agent, which has been reported to improve medication treatment outcomes in patients with MDD. Objective: The aim of this study was to review the literature on the clinical utility of folate augmentation for patients with MDD. Folate and depression: Patients with depression have consistently been found to have lower levels of serum and red blood cell folate than normal or nondepressed psychiatric patients. Decreased folate levels have been associated with lowered response rates to standard antidepressant pharmacotherapy. Recent studies have shown that augmentation with a folate supplement increases medication response in both treatment-naïve and treatment-resistant depressed patients irrespective of whether there is folate deficiency. Conclusions: Depressed patients with both low and normal folate levels may benefit from augmenting a primary antidepressant medication either initially, at the onset of treatment, or later after some degree of treatment resistance has been recognized.

UR - http://www.scopus.com/inward/record.url?scp=42049111662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049111662&partnerID=8YFLogxK

U2 - 10.1089/acm.2007.0663

DO - 10.1089/acm.2007.0663

M3 - Article

C2 - 18370582

AN - SCOPUS:42049111662

VL - 14

SP - 277

EP - 285

JO - Journal of Alternative and Complementary Medicine

JF - Journal of Alternative and Complementary Medicine

SN - 1075-5535

IS - 3

ER -